Clinical trials: Fatigue Related to Cancer Treatment
Ovarian Cancer, Advanced Ovarian Carcinoma
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
The purpose of this study is to see whether a supportive intervention (REVITALIZE) reduces fatigue and its impact on daily life and activities for participants with ovarian cancer taking PARP inhibitors.
- Conditions
- Ovarian Cancer, Advanced Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Cancer
- Trial name
- NCT06710548
- Testing
- REVITALIZE Intervention, Educational Materials
- Where
- 6 sites in United States
- Volunteers
- 240 people
- Sponsor
- Dana-Farber Cancer Institute